FAQ

How do I become an MRC Data Partner?

After sending an inquiry via our Contact page, we will send a draft agreeement and pricing options for our Data Partner service. Once a contract is signed and payment remitted for a 6-month or 12-month term, we will send a Welcome email with a generated user name and passcode. You will need these to access Reports on this site. When new Reports are posted, or updates issued on a concern we cover, you will be notified promptly by email.

How do I access MRC reports?

After signing a contract and remitting payment for a 6-month or 12-month term of our Data Partner service, we will send an email with a generated user name and passcode. You will need these to access Reports on this site. When new Reports are posted, or updates issued on a concern we cover, you will be notified promptly by email.

If you are having any difficulties, please Contact us directly.

May I share a report I have access to?

Sharing of our research reports with others is authorized to the extent it is not made widely accessible on a public domain.

Can I cancel an order/subscription and get a refund?

If you have submitted a payment and we have granted access to our Data Partner service, then unfortunately we cannot issue a refund, as the product itself, which is the content of our research, shall be considered to have been “used” by you or your firm.

What if I can't find my question in this list?

We may be contacted directly with any questions that you have.

How do I contact you?

Please use our Contact page.

Who are the people behind Medical Research Collaborative?

Medical Research Collaborative, LLC (“MRC”) is an independent research firm founded in March of 2019. As the name implies, MRC collaborates with experts in various fields of endeavor in the process of procuring research reports on companies in the healthcare sector.

The piece, entitled “AMRN: Market Headwinds and Inherent Weakness of the Vascepa IP,” as well as any citizen petitions written under the MRC moniker, were ultimately constructed by Steven Giardino, the President/Owner of MRC, who has extensive knowledge in various pharmaceutical/medical science topics, in regulatory science, and in patent law, but has not earned established degrees in these fields.

The goal of MRC is to make the research that we produce the focus; in our view, the work should stand or fall based on its own merits, including the peer-reviewed authorship of the experts it cites. Further, as the subject matter entailing our focus can at times be controversial, it is company policy that the identities of the collaborators of MRC remain anonymous.